17 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
MetLife (MET) Reports Q1 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2266517/metlife-met-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2266517 May 01, 2024 - The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Warrior Met Coal (HCC) Q1 Earnings and Revenues Beat Estimates https://www.zacks.com/stock/news/2266454/warrior-met-coal-hcc-q1-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2266454 May 01, 2024 - Warrior Met Coal (HCC) delivered earnings and revenue surprises of 30.20% and 24.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
How Should You Play MetLife (MET) Ahead of Q1 Earnings? https://www.zacks.com/stock/news/2264458/how-should-you-play-metlife-met-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264458 Apr 29, 2024 - MetLife's (MET) Q1 results are likely to reflect gains from strong contributions from Group Benefits, RIS and Asia segments, partly offset by an elevated expense level.
North Oaks withdraws request for density exemption from Met Council https://www.startribune.com/north-oaks-withdraws-ask-for-density-exemption-from-met-council/600361826/ Apr 26, 2024 - Met Council staff members said the planned development didn't meet density requirements, and that granting North Oaks an exception could set a bad precedent.
Buy The Dip In Warrior Met Coal https://seekingalpha.com/article/4680038-buy-the-dip-in-warrior-met-coal?source=feed_all_articles Mar 22, 2024 - Coal stocks tend to struggle during shoulder season, and Warrior Met Coal has the potential for attractive cash flow generation by 2026. Read more on HCC stock.
Top Stock Reports for Disney, Morgan Stanley & Stryker https://www.zacks.com/commentary/2244021/top-stock-reports-for-disney-morgan-stanley-stryker?cid=CS-ZC-FT-research_daily-2244021 Mar 21, 2024 - Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Morgan Stanley (MS) and Stryker Corporation (SYK).
MetLife (MET) Rises 11.4% in 3 Months: More Room for Growth? https://www.zacks.com/stock/news/2244380/metlife-met-rises-11-4-in-3-months-more-room-for-growth?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2244380 Mar 21, 2024 - MetLife's (MET) cost-saving efforts and growth in Latin America business are major tailwinds.
Only seven countries met WHO air standards in 2023, report says https://www.washingtonpost.com/climate-environment/2024/03/20/iqair-air-quality-report-who/ Mar 20, 2024 - Few countries met World Health Organization standards for PM 2.5 pollution, the most dangerous kind for human health. The United States was not one of them.
MetLife (MET) Rolls Out Annuity Offering to Aid Retirees https://www.zacks.com/stock/news/2234129/metlife-met-rolls-out-annuity-offering-to-aid-retirees?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234129 Feb 29, 2024 - MetLife (MET) joins forces with Fidelity and Micruity to offer a guaranteed income offering and enable retired individuals to envision a secure financial future.
Palatin Stock Drops As Co-Primary Sign, Secondary Sign Endpoints Not Met In PL9643 Phase 3 DED Trial https://www.rttnews.com/story.aspx?Id=3428191 Feb 28, 2024 - Palatin Technologies, Inc.'s (PTN) shares were losing more than 38 percent in pre-market activity on the NYSE after the biopharmaceutical company announced that co-primary sign endpoint and secondary sign endpoints in its PL9643 MELODY-1 pivotal Phase 3 clinical trial in dry eye disease did not achieve statistical significance.

Pages: 12

Page 1